US$ 29.17
why is bpc 157 banned by fda BPC-157 Approval Status 2026: Clinical Trials Regeneration or Risk? A Narrative
Description
NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: reversal by the pentadecapeptide BPC 157 in rats and guinea pigs

The peptide needs to be administered as close to the affected level as practically possible for maximum effect

Always use an insulin syringe marked with units for accurate measurement

At ~6,667 mcg/mL, 1 unit 66.7 mcg
